Recombinant multi-species FANCD2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FANCD2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group D2. This protein is monoubiquinated in response to DNA damage, resulting in its localization to nuclear foci with other proteins (BRCA1 AND BRCA2) involved in homology-directed DNA repair. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
The Alternative Names of target: 2410150O07Rik,FA-D2,FA4,FACD,FAD,FAD2,FANCD,FANCD2,Fancd2,Fanconi anemia group D2 protein,Protein FACD2
Go
to FANCD2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP6455-Ag-1/ GM-Tg-hg-IP6455-Ag-2 | Human FANCD2 protein | Human |
| GM-Tg-rg-IP6455-Ag-1/ GM-Tg-rg-IP6455-Ag-2 | Rat FANCD2 protein | Rat |
| GM-Tg-mg-IP6455-Ag-1/ GM-Tg-mg-IP6455-Ag-2 | Mouse FANCD2 protein | Mouse |
| GM-Tg-cynog-IP6455-Ag-1/ GM-Tg-cynog-IP6455-Ag-2 | Cynomolgus/Rhesus macaque FANCD2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP6455-Ag-1/ GM-Tg-felg-IP6455-Ag-2 | Feline FANCD2 protein | Feline |
| GM-Tg-cang-IP6455-Ag-1/ GM-Tg-cang-IP6455-Ag-2 | Canine FANCD2 protein | Canine |
| GM-Tg-bovg-IP6455-Ag-1/ GM-Tg-bovg-IP6455-Ag-2 | Bovine FANCD2 protein | Bovine |
| GM-Tg-equg-IP6455-Ag-1/ GM-Tg-equg-IP6455-Ag-2 | Equine FANCD2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP6455-Ag-1/ GM-Tg-hg-IP6455-Ag-2;
GM-Tg-rg-IP6455-Ag-1/ GM-Tg-rg-IP6455-Ag-2;
GM-Tg-mg-IP6455-Ag-1/ GM-Tg-mg-IP6455-Ag-2; GM-Tg-cynog-IP6455-Ag-1/ GM-Tg-cynog-IP6455-Ag-2; GM-Tg-felg-IP6455-Ag-1/ GM-Tg-felg-IP6455-Ag-2; GM-Tg-cang-IP6455-Ag-1/ GM-Tg-cang-IP6455-Ag-2; GM-Tg-bovg-IP6455-Ag-1/ GM-Tg-bovg-IP6455-Ag-2; GM-Tg-equg-IP6455-Ag-1/ GM-Tg-equg-IP6455-Ag-2 |
| Products Name | FANCD2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | FANCD2 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FANCD2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.